HEADER TRANSFERASE 18-MAY-18 5ZXB TITLE CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND 10D COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACTIVATED CDC42 KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ACK-1,TYROSINE KINASE NON-RECEPTOR PROTEIN 2; COMPND 5 EC: 2.7.10.2,2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNK2, ACK1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS INHIBITOR, KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR E.M.HONG,H.L.KIM,T.B.SIM REVDAT 3 27-MAR-24 5ZXB 1 COMPND REVDAT 2 10-OCT-18 5ZXB 1 COMPND JRNL REVDAT 1 26-SEP-18 5ZXB 0 JRNL AUTH H.CHO,I.SHIN,E.JU,S.CHOI,W.HUR,H.KIM,E.HONG,N.D.KIM, JRNL AUTH 2 H.G.CHOI,N.S.GRAY,T.SIM JRNL TITL FIRST SAR STUDY FOR OVERRIDING NRAS MUTANT DRIVEN ACUTE JRNL TITL 2 MYELOID LEUKEMIA. JRNL REF J. MED. CHEM. V. 61 8353 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30153003 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00882 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.78 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 28647 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880 REMARK 3 FREE R VALUE TEST SET COUNT : 1398 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.7800 - 4.7316 0.99 2858 160 0.1901 0.2536 REMARK 3 2 4.7316 - 3.7568 1.00 2794 152 0.1784 0.2059 REMARK 3 3 3.7568 - 3.2823 0.99 2788 135 0.1896 0.2409 REMARK 3 4 3.2823 - 2.9823 1.00 2762 145 0.2089 0.2801 REMARK 3 5 2.9823 - 2.7687 0.99 2741 128 0.2151 0.2376 REMARK 3 6 2.7687 - 2.6055 0.99 2754 127 0.2242 0.2756 REMARK 3 7 2.6055 - 2.4750 0.99 2728 151 0.2384 0.3151 REMARK 3 8 2.4750 - 2.3673 0.99 2707 143 0.2704 0.3483 REMARK 3 9 2.3673 - 2.2762 0.97 2661 136 0.2908 0.3389 REMARK 3 10 2.2762 - 2.1976 0.89 2456 121 0.2998 0.3218 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.320 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4080 REMARK 3 ANGLE : 1.468 5530 REMARK 3 CHIRALITY : 0.067 593 REMARK 3 PLANARITY : 0.008 696 REMARK 3 DIHEDRAL : 10.664 3359 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND (RESID 117 THROUGH 119 OR REMARK 3 RESID 121 THROUGH 134 OR RESID 139 REMARK 3 THROUGH 225 OR RESID 227 THROUGH 319 OR REMARK 3 RESID 321 THROUGH 378 OR RESID 380 REMARK 3 THROUGH 388 OR (RESID 389 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB OR REMARK 3 NAME CG OR NAME CD OR NAME OE1 OR NAME REMARK 3 NE2)))) REMARK 3 SELECTION : (CHAIN B AND (RESID 117 THROUGH 119 OR REMARK 3 RESID 121 THROUGH 160 OR RESID 170 REMARK 3 THROUGH 319 OR RESID 321 THROUGH 378 OR REMARK 3 RESID 380 THROUGH 389)) REMARK 3 ATOM PAIRS NUMBER : 2188 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5ZXB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1300007742. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-APR-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 5C (4A) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97950 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28669 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.198 REMARK 200 RESOLUTION RANGE LOW (A) : 36.775 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS PH6.3 0.2M AMSO4 28% REMARK 280 PEG3350 10MM DTT, EVAPORATION, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.56000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 135 REMARK 465 SER A 136 REMARK 465 PHE A 137 REMARK 465 LYS A 161 REMARK 465 PRO A 162 REMARK 465 ASP A 163 REMARK 465 VAL A 164 REMARK 465 LEU A 165 REMARK 465 SER A 166 REMARK 465 GLN A 167 REMARK 465 PRO A 168 REMARK 465 GLU A 169 REMARK 465 GLY A 272 REMARK 465 LEU A 273 REMARK 465 MET A 274 REMARK 465 ARG A 275 REMARK 465 ALA A 276 REMARK 465 LEU A 277 REMARK 465 PRO A 278 REMARK 465 GLN A 279 REMARK 465 ASN A 280 REMARK 465 ASP A 281 REMARK 465 ASP A 282 REMARK 465 HIS A 283 REMARK 465 TYR A 284 REMARK 465 VAL A 285 REMARK 465 MET A 286 REMARK 465 GLN A 287 REMARK 465 GLU A 288 REMARK 465 HIS A 289 REMARK 465 ARG A 290 REMARK 465 LYS A 291 REMARK 465 VAL A 292 REMARK 465 PRO A 390 REMARK 465 THR A 391 REMARK 465 GLY B 135 REMARK 465 SER B 136 REMARK 465 PHE B 137 REMARK 465 GLY B 138 REMARK 465 LYS B 161 REMARK 465 PRO B 162 REMARK 465 ASP B 163 REMARK 465 VAL B 164 REMARK 465 LEU B 165 REMARK 465 SER B 166 REMARK 465 LEU B 225 REMARK 465 GLY B 272 REMARK 465 LEU B 273 REMARK 465 MET B 274 REMARK 465 ARG B 275 REMARK 465 ALA B 276 REMARK 465 LEU B 277 REMARK 465 PRO B 278 REMARK 465 GLN B 279 REMARK 465 ASN B 280 REMARK 465 ASP B 281 REMARK 465 ASP B 282 REMARK 465 HIS B 283 REMARK 465 TYR B 284 REMARK 465 VAL B 285 REMARK 465 MET B 286 REMARK 465 GLN B 287 REMARK 465 GLU B 288 REMARK 465 HIS B 289 REMARK 465 ARG B 290 REMARK 465 LYS B 291 REMARK 465 VAL B 292 REMARK 465 PRO B 390 REMARK 465 THR B 391 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 507 O HOH A 548 2.09 REMARK 500 O ALA B 388 O HOH B 501 2.11 REMARK 500 OD1 ASP A 215 O HOH A 501 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 131 N - CA - CB ANGL. DEV. = -11.5 DEGREES REMARK 500 LYS A 131 CA - CB - CG ANGL. DEV. = 20.3 DEGREES REMARK 500 LYS A 151 CA - CB - CG ANGL. DEV. = 21.1 DEGREES REMARK 500 LYS A 151 CD - CE - NZ ANGL. DEV. = -14.2 DEGREES REMARK 500 ARG A 191 CG - CD - NE ANGL. DEV. = 13.5 DEGREES REMARK 500 ARG A 191 NE - CZ - NH1 ANGL. DEV. = 6.0 DEGREES REMARK 500 ARG A 191 NE - CZ - NH2 ANGL. DEV. = -5.4 DEGREES REMARK 500 ARG B 216 CB - CG - CD ANGL. DEV. = 24.4 DEGREES REMARK 500 GLN B 221 N - CA - CB ANGL. DEV. = 12.2 DEGREES REMARK 500 GLN B 221 CA - CB - CG ANGL. DEV. = 16.1 DEGREES REMARK 500 ARG B 263 CG - CD - NE ANGL. DEV. = 14.6 DEGREES REMARK 500 ARG B 263 CD - NE - CZ ANGL. DEV. = 9.1 DEGREES REMARK 500 GLU B 354 N - CA - CB ANGL. DEV. = 17.8 DEGREES REMARK 500 GLU B 354 CA - CB - CG ANGL. DEV. = 23.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 129 -140.68 -110.13 REMARK 500 ARG A 251 -2.72 78.84 REMARK 500 ASP A 252 45.57 -148.29 REMARK 500 ASP A 270 87.59 -159.07 REMARK 500 ARG A 305 45.99 39.98 REMARK 500 LEU B 129 -140.74 -113.16 REMARK 500 PRO B 168 -92.42 -115.74 REMARK 500 HIS B 220 63.95 -114.70 REMARK 500 ARG B 251 -3.02 79.44 REMARK 500 ASP B 252 48.53 -152.30 REMARK 500 ASP B 270 90.46 -162.70 REMARK 500 ARG B 305 42.16 38.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLN B 221 GLY B 222 -148.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 HIS B 223 0.06 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9KO A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9KO B 401 DBREF 5ZXB A 117 391 UNP Q07912 ACK1_HUMAN 117 391 DBREF 5ZXB B 117 391 UNP Q07912 ACK1_HUMAN 117 391 SEQRES 1 A 275 LEU THR CYS LEU ILE GLY GLU LYS ASP LEU ARG LEU LEU SEQRES 2 A 275 GLU LYS LEU GLY ASP GLY SER PHE GLY VAL VAL ARG ARG SEQRES 3 A 275 GLY GLU TRP ASP ALA PRO SER GLY LYS THR VAL SER VAL SEQRES 4 A 275 ALA VAL LYS CYS LEU LYS PRO ASP VAL LEU SER GLN PRO SEQRES 5 A 275 GLU ALA MET ASP ASP PHE ILE ARG GLU VAL ASN ALA MET SEQRES 6 A 275 HIS SER LEU ASP HIS ARG ASN LEU ILE ARG LEU TYR GLY SEQRES 7 A 275 VAL VAL LEU THR PRO PRO MET LYS MET VAL THR GLU LEU SEQRES 8 A 275 ALA PRO LEU GLY SER LEU LEU ASP ARG LEU ARG LYS HIS SEQRES 9 A 275 GLN GLY HIS PHE LEU LEU GLY THR LEU SER ARG TYR ALA SEQRES 10 A 275 VAL GLN VAL ALA GLU GLY MET GLY TYR LEU GLU SER LYS SEQRES 11 A 275 ARG PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN LEU LEU SEQRES 12 A 275 LEU ALA THR ARG ASP LEU VAL LYS ILE GLY ASP PHE GLY SEQRES 13 A 275 LEU MET ARG ALA LEU PRO GLN ASN ASP ASP HIS TYR VAL SEQRES 14 A 275 MET GLN GLU HIS ARG LYS VAL PRO PHE ALA TRP CYS ALA SEQRES 15 A 275 PRO GLU SER LEU LYS THR ARG THR PHE SER HIS ALA SER SEQRES 16 A 275 ASP THR TRP MET PHE GLY VAL THR LEU TRP GLU MET PHE SEQRES 17 A 275 THR TYR GLY GLN GLU PRO TRP ILE GLY LEU ASN GLY SER SEQRES 18 A 275 GLN ILE LEU HIS LYS ILE ASP LYS GLU GLY GLU ARG LEU SEQRES 19 A 275 PRO ARG PRO GLU ASP CYS PRO GLN ASP ILE TYR ASN VAL SEQRES 20 A 275 MET VAL GLN CYS TRP ALA HIS LYS PRO GLU ASP ARG PRO SEQRES 21 A 275 THR PHE VAL ALA LEU ARG ASP PHE LEU LEU GLU ALA GLN SEQRES 22 A 275 PRO THR SEQRES 1 B 275 LEU THR CYS LEU ILE GLY GLU LYS ASP LEU ARG LEU LEU SEQRES 2 B 275 GLU LYS LEU GLY ASP GLY SER PHE GLY VAL VAL ARG ARG SEQRES 3 B 275 GLY GLU TRP ASP ALA PRO SER GLY LYS THR VAL SER VAL SEQRES 4 B 275 ALA VAL LYS CYS LEU LYS PRO ASP VAL LEU SER GLN PRO SEQRES 5 B 275 GLU ALA MET ASP ASP PHE ILE ARG GLU VAL ASN ALA MET SEQRES 6 B 275 HIS SER LEU ASP HIS ARG ASN LEU ILE ARG LEU TYR GLY SEQRES 7 B 275 VAL VAL LEU THR PRO PRO MET LYS MET VAL THR GLU LEU SEQRES 8 B 275 ALA PRO LEU GLY SER LEU LEU ASP ARG LEU ARG LYS HIS SEQRES 9 B 275 GLN GLY HIS PHE LEU LEU GLY THR LEU SER ARG TYR ALA SEQRES 10 B 275 VAL GLN VAL ALA GLU GLY MET GLY TYR LEU GLU SER LYS SEQRES 11 B 275 ARG PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN LEU LEU SEQRES 12 B 275 LEU ALA THR ARG ASP LEU VAL LYS ILE GLY ASP PHE GLY SEQRES 13 B 275 LEU MET ARG ALA LEU PRO GLN ASN ASP ASP HIS TYR VAL SEQRES 14 B 275 MET GLN GLU HIS ARG LYS VAL PRO PHE ALA TRP CYS ALA SEQRES 15 B 275 PRO GLU SER LEU LYS THR ARG THR PHE SER HIS ALA SER SEQRES 16 B 275 ASP THR TRP MET PHE GLY VAL THR LEU TRP GLU MET PHE SEQRES 17 B 275 THR TYR GLY GLN GLU PRO TRP ILE GLY LEU ASN GLY SER SEQRES 18 B 275 GLN ILE LEU HIS LYS ILE ASP LYS GLU GLY GLU ARG LEU SEQRES 19 B 275 PRO ARG PRO GLU ASP CYS PRO GLN ASP ILE TYR ASN VAL SEQRES 20 B 275 MET VAL GLN CYS TRP ALA HIS LYS PRO GLU ASP ARG PRO SEQRES 21 B 275 THR PHE VAL ALA LEU ARG ASP PHE LEU LEU GLU ALA GLN SEQRES 22 B 275 PRO THR HET 9KO A 401 48 HET 9KO B 401 48 HETNAM 9KO N-{3-[7-{[6-(4-ACETYLPIPERAZIN-1-YL)PYRIDIN-3- HETNAM 2 9KO YL]AMINO}-1-METHYL-2-OXO-1,4-DIHYDROPYRIMIDO[4,5- HETNAM 3 9KO D]PYRIMIDIN-3(2H)-YL]-4-METHYLPHENYL}-3- HETNAM 4 9KO (TRIFLUOROMETHYL)BENZAMIDE FORMUL 3 9KO 2(C33 H32 F3 N9 O3) FORMUL 5 HOH *93(H2 O) HELIX 1 AA1 GLY A 122 LYS A 124 5 3 HELIX 2 AA2 MET A 171 SER A 183 1 13 HELIX 3 AA3 LEU A 213 HIS A 220 1 8 HELIX 4 AA4 GLN A 221 PHE A 224 5 4 HELIX 5 AA5 LEU A 225 LYS A 246 1 22 HELIX 6 AA6 ALA A 254 ARG A 256 5 3 HELIX 7 AA7 PRO A 293 CYS A 297 5 5 HELIX 8 AA8 ALA A 298 ARG A 305 1 8 HELIX 9 AA9 SER A 308 THR A 325 1 18 HELIX 10 AB1 ASN A 335 LYS A 345 1 11 HELIX 11 AB2 PRO A 357 TRP A 368 1 12 HELIX 12 AB3 LYS A 371 ARG A 375 5 5 HELIX 13 AB4 THR A 377 GLN A 389 1 13 HELIX 14 AB5 GLY B 122 LYS B 124 5 3 HELIX 15 AB6 GLU B 169 SER B 183 1 15 HELIX 16 AB7 LEU B 213 LYS B 219 1 7 HELIX 17 AB8 GLY B 227 LYS B 246 1 20 HELIX 18 AB9 ALA B 254 ARG B 256 5 3 HELIX 19 AC1 PRO B 293 CYS B 297 5 5 HELIX 20 AC2 ALA B 298 ARG B 305 1 8 HELIX 21 AC3 SER B 308 THR B 325 1 18 HELIX 22 AC4 ASN B 335 LYS B 345 1 11 HELIX 23 AC5 PRO B 357 TRP B 368 1 12 HELIX 24 AC6 LYS B 371 ARG B 375 5 5 HELIX 25 AC7 THR B 377 GLN B 389 1 13 SHEET 1 AA1 6 CYS A 119 LEU A 120 0 SHEET 2 AA1 6 LEU A 192 VAL A 196 1 O VAL A 195 N CYS A 119 SHEET 3 AA1 6 LYS A 202 GLU A 206 -1 O VAL A 204 N TYR A 193 SHEET 4 AA1 6 THR A 152 CYS A 159 -1 N ALA A 156 O THR A 205 SHEET 5 AA1 6 VAL A 140 ASP A 146 -1 N TRP A 145 O VAL A 153 SHEET 6 AA1 6 LEU A 126 GLY A 133 -1 N LEU A 132 O VAL A 140 SHEET 1 AA2 3 GLY A 211 SER A 212 0 SHEET 2 AA2 3 LEU A 258 THR A 262 -1 O LEU A 260 N GLY A 211 SHEET 3 AA2 3 LEU A 265 ILE A 268 -1 O LYS A 267 N LEU A 259 SHEET 1 AA3 6 CYS B 119 LEU B 120 0 SHEET 2 AA3 6 LEU B 192 VAL B 196 1 O TYR B 193 N CYS B 119 SHEET 3 AA3 6 LYS B 202 GLU B 206 -1 O VAL B 204 N GLY B 194 SHEET 4 AA3 6 THR B 152 CYS B 159 -1 N LYS B 158 O MET B 203 SHEET 5 AA3 6 VAL B 140 ASP B 146 -1 N ARG B 141 O VAL B 157 SHEET 6 AA3 6 LEU B 126 GLY B 133 -1 N LEU B 129 O ARG B 142 SHEET 1 AA4 3 GLY B 211 SER B 212 0 SHEET 2 AA4 3 LEU B 258 THR B 262 -1 O LEU B 260 N GLY B 211 SHEET 3 AA4 3 LEU B 265 ILE B 268 -1 O LYS B 267 N LEU B 259 CISPEP 1 PRO A 199 PRO A 200 0 -7.87 CISPEP 2 PRO B 199 PRO B 200 0 -8.38 SITE 1 AC1 17 LEU A 132 ALA A 156 LYS A 158 GLU A 177 SITE 2 AC1 17 MET A 181 LEU A 184 THR A 205 GLU A 206 SITE 3 AC1 17 ALA A 208 GLY A 211 PHE A 248 LEU A 259 SITE 4 AC1 17 ILE A 268 GLY A 269 ASP A 270 PHE A 271 SITE 5 AC1 17 HOH A 541 SITE 1 AC2 18 LEU B 132 VAL B 140 ALA B 156 LYS B 158 SITE 2 AC2 18 GLU B 177 MET B 181 LEU B 184 THR B 205 SITE 3 AC2 18 GLU B 206 LEU B 207 ALA B 208 GLY B 211 SITE 4 AC2 18 PHE B 248 HIS B 250 GLY B 269 ASP B 270 SITE 5 AC2 18 PHE B 271 HOH B 509 CRYST1 71.182 43.120 93.891 90.00 98.34 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014048 0.000000 0.002060 0.00000 SCALE2 0.000000 0.023191 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010765 0.00000